Skip to main content
. 2025 May 16;25:710. doi: 10.1186/s12879-025-11101-3

Table 3.

Laboratory tests of ATBL in the hematogenous dissemination group and non - hematogenous dissemination group

Laboratory tests Hematogenous Dissemination group (n = 75) Non-hematogenous Dissemination group (n = 103) P
CD4+ T cell counts (cells/µL) * 145 (57– 304) 269 (196–362.5) < 0.001
Lymphocyte counts (× 109 cells/L) # 0.70 (0.42–1.31) 0.92 (0.78–1.24) 0.003
Tuberculin skin test (positive) & 37 (37/72, 51.4%) 66 (66/100 66%) 0.054
Smear microscopy test for AFB (positive)$ 28 (28/72, 38.9%) 13 (13/97, 13.4%) < 0.001

ATBL, abdominal tuberculous lymphadenopathy; AFB, acid-fast bacilli; *, 55 patients were no data; #, 6 patients were no data; &, 6 patients were no data; $, 9 patients were no data